Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention1: Group A: Rasnadi Basti Rectal 700ml At
morning
Total 16 days, After
cessation of menses
for 2 consecutive
cycles
Control Intervention1: Group B: Vardhamana
Shatapushpa
Kalpa
Oral 6
Sponsors
IPGT and RA
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients having active married life minimum 1 year and suffering from Infertility with atleast2 or more consecutive anovulatory cycles. 2. Primary and secondary both types of infertile patients having anovulatory cycle or with immature ovarian follicle. 3. Patient eligible for Basti. 4. Patient willing for Basti. 5. Patients willing to participate in trial
Exclusion criteria
Exclusion criteria: 1. Female Patients having age less than 20years and more than 40years. 2. Congenital deformities and infectious diseases of reproductive tract like tuberculosis, Sexually transmitted diseases and carcinoma 3. Chronic systemic diseases like Uncontrolled Diabetes &Hypertension, HIV, TB, etc. 4. Patient not eligible for Basti. 5. Patient not willing for Basti 6. Pitta prakriti females.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drugs will induce the ovulation. Timepoint: After the follow up period | — |
Secondary
| Measure | Time frame |
|---|---|
| Trail drugs will improve menstrual abnormalities associated with anovulation like irregular, scanty menstruation, dysmenorrhoea.Timepoint: After the follow up period | — |
Countries
India
Contacts
Public ContactProf Shilpa Donga
IPGT and RA
Outcome results
None listed